Freed Investment Group - CITIUS PHARMACEUTICALS INC ownership

CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 23 filers reported holding CITIUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Freed Investment Group ownership history of CITIUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$107,000
+311.5%
52,900
+262.3%
0.08%
+256.5%
Q1 2021$26,000
-10.3%
14,600
-48.8%
0.02%
-14.8%
Q4 2020$29,00028,5000.03%
Other shareholders
CITIUS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 498,783$3940.05%
Inspire Advisors, LLC 195,946$154,7970.04%
Wealth Advisory Solutions, LLC 155,850$123,1220.03%
Miller Investment Management, LP 50,000$39,5000.01%
Virtu Financial LLC 39,005$310.00%
Pasadena Private Wealth, LLC 10,965$8,6620.00%
Jump Financial, LLC 49,251$38,9080.00%
Csenge Advisory Group 15,000$11,8500.00%
Qube Research & Technologies Ltd 120,580$95,2580.00%
Syverson Strege & Co 2,145$1,6950.00%
View complete list of CITIUS PHARMACEUTICALS INC shareholders